We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.33B
AUM Growth
+$172M
Cap. Flow
+$108M
Cap. Flow %
8.1%
Top 10 Hldgs %
18.38%
Holding
1,833
New
283
Increased
650
Reduced
474
Closed
294

Top Sells

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$17.3M
2
MA icon
Mastercard
MA
+$7.29M
3
ELV icon
Elevance Health
ELV
+$6.89M
4
BKNG icon
Booking.com
BKNG
+$6.27M
5
IBM icon
IBM
IBM
+$5.77M

Sector Composition

Rank Sector Weight
1 Technology 17%
2 Healthcare 14.77%
3 Financials 11.38%
4 Consumer Discretionary 8.43%
5 Industrials 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OOMA icon
1251
Ooma
OOMA
$588M
$7K ﹤0.01%
442
-404
-48% -$6.48K
PTN
1252
Palatin Technologies
PTN
$14M
$7K ﹤0.01%
+5
New +$6.18K
REG icon
1253
Regency Centers
REG
$14.1B
$7K ﹤0.01%
107
RICK icon
1254
RCI Hospitality Holdings
RICK
$201M
$7K ﹤0.01%
234
-120
-34% -$3.83K
SNDA icon
1255
Sonida Senior Living
SNDA
$1.91B
$7K ﹤0.01%
+50
New +$6.79K
SPOK icon
1256
Spok Holdings
SPOK
$236M
$7K ﹤0.01%
441
+377
+589% +$5.7K
SUPN icon
1257
Supernus Pharmaceuticals
SUPN
$2.72B
$7K ﹤0.01%
144
-96
-40% -$4.74K
TOVX icon
1258
Theriva Biologics
TOVX
$10.3M
$7K ﹤0.01%
10
+9
+900% +$9.95K
VFC icon
1259
VF Corp
VFC
$5.8B
$7K ﹤0.01%
76
VRA icon
1260
Vera Bradley
VRA
$96.1M
$7K ﹤0.01%
455
+356
+360% +$5.2K
INFI
1261
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$7K ﹤0.01%
2,544
+1,026
+68% +$2.12K
VIVO
1262
DELISTED
Meridian Bioscience Inc
VIVO
$7K ﹤0.01%
486
-313
-39% -$4.85K
LUB
1263
DELISTED
Luby's Inc.
LUB
$7K ﹤0.01%
4,013
+1,543
+62% +$3.41K
XLRN
1264
DELISTED
Acceleron Pharma
XLRN
$7K ﹤0.01%
123
-4
-3% -$197
ENT
1265
DELISTED
Global Eagle Entertainment Inc.
ENT
$7K ﹤0.01%
103
+89
+636% +$5.73K
QES
1266
DELISTED
Quintana Energy Services Inc.
QES
$7K ﹤0.01%
922
-1,068
-54% -$8.24K
TTPH
1267
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$7K ﹤0.01%
+122
New +$7.79K
QHC
1268
DELISTED
Quorum Health Corporation
QHC
$7K ﹤0.01%
1,134
+1,093
+2,666% +$5.02K
GNMX
1269
DELISTED
Aevi Genomic Medicine Inc
GNMX
$7K ﹤0.01%
5,405
+3,067
+131% +$3.43K
TSRO
1270
DELISTED
TESARO, Inc.
TSRO
$7K ﹤0.01%
+181
New +$6.39K
SCG
1271
DELISTED
Scana
SCG
$7K ﹤0.01%
190
SYNT
1272
DELISTED
Syntel Inc
SYNT
$7K ﹤0.01%
178
-21,548
-99% -$862K
HIBB
1273
DELISTED
Hibbett, Inc. Common Stock
HIBB
$7K ﹤0.01%
439
-588
-57% -$13.3K
MCF
1274
DELISTED
Contango Oil & Gas Co.
MCF
$7K ﹤0.01%
1,131
+852
+305% +$5.05K
BAS
1275
DELISTED
Basis Energy Services, Inc.
BAS
$7K ﹤0.01%
698
-361
-34% -$3.5K

Similar funds

Meeder Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Meeder Asset Management held 1,833 positions worth $1.33B, up 15% from $1.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Meeder Asset Management deployed $108M of net new capital in Q3 2018, opening 283 new positions and adding to 650 existing holdings. Its largest new stake was Humana: 24,758 shares worth $8.38M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $17.3M trimmed.

  • Meeder Asset Management's largest Q3 2018 buy was Humana: 24,758 shares worth $8.38M.
  • Meeder Asset Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2018, an estimated $15.6M increase.
  • Meeder Asset Management's biggest Q3 2018 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $17.3M.
  • Meeder Asset Management fully exited Centene in Q3 2018, selling an estimated $3.09M.
  • Meeder Asset Management's ten largest holdings make up 18% of its $1.33B portfolio in Q3 2018.
  • Meeder Asset Management opened 283 new positions and closed 294 in Q3 2018.
  • Meeder Asset Management's portfolio value rose 15% quarter-over-quarter to $1.33B.

Based on Meeder Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.